Defective Drugs:

Bextra Linked to Heart Attack, Stevens Johnson Syndrome

Bextra ClassAction.org Alert

This Alert Affects:
If you have used Bextra as directed by a doctor and suffered a heart attack, stroke, or serious skin reactions, you may be entitled to recover damages.
Damages: Use of Bextra has been shown to produce higher than normal cardiovascular events for patients. This includes heart attacks and strokes. It has also been linked to potentially life threatening skin conditions including Stevens Johnson Syndrome, toxic epidermal necrolysis, and erythema multiforme.
Company(ies): Pfizer
Additional Details: Bextra is prescription drug used to treat arthritis, menstrual cramps, and associated problems. It is classified as a Non-Steroidal Anti-Inflammatory Drug (NSAID) and helps reduce pain, swelling, and fever without causing stomach irritation.
Date: On April 7, 2005, Pfizer removed Bextra from the market in response to pressure from the FDA.

Bextra Help :

If you believe you or someone you know has been affected by Bextra submit your details for a free evaluation. There is no cost or obligation.

Bextra

Bextra

Bextra (valdecoxib) is a non-steroidal anti inflammatory drug. It was approved for use in the United States for treating arthritis pain and severe menstrual cramps in November 2001. Several reports of Bextra side effects indicate that Bextra users are at an increased risk for serious skin conditions, including Stevens Johnson Syndrome, toxic epidermal necrolysis (TEN), and erythema multiforme (EM). Stevens Johnson Syndrome is a rare inflammatory skin disorder that can be fatal in severe cases. Studies have also suggested that Bextra may be linked to an increased risk of heart attacks and strokes. Patients who have suffered serious medical problems after taking Bextra may be eligible to file a Bextra lawsuit. If you believe you might have a case, it is advisable to contact a lawyer as soon as possible. Your lawyer will help you understand your rights and determine the best course of action to take.

Comments

Report a Complaint
Yes No
Yes I agree to the Class Action Disclaimers.
Click here to review.
2098 →

Spread The Word